Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2018-08-08 | Name: Robert Watson, Age: 61, Position: Director, Independent, No director compensation listed for Robert Watson in the Directors’ fees table. |
| 2019-03-26 | Robert Watson 62 Director, Independent ... Committees: Audit, Compensation, and Nominating ... Compensation of Directors During Year Ended September 30, 2018 ... Robert Watson $30,000 Fees, $0 Stock Awards, $168,332 Option Awards, Total $198,332. |
| 2020-03-04 | Robert Watson has been a director of CEL-SCI since December 2017. Mr. Watson is the President and CEO of Juvare, LLC (formerly Intermedix, Inc.) since July 2017. Immediately prior to joining Intermedix, now Juvare, he was the President and Chief Growth Officer of NantHealth, Inc. (Nasdaq: NH) from January 2015 to May 2017. Prior to NantHealth, he was President and CEO of Streamline Health, Inc. (Nasdaq: STRM) from January 2011 to January 2015. Mr. Watson has over 35 years of experience in the healthcare information technology industry as a CEO, board member and advisor to multiple healthcare information technology companies. He has participated in over 75 acquisitions, raised nearly $750 million in capital, completed three public offerings and successfully sold four companies. Mr. Watson holds a MBA from the Wharton School of Business at the University of Pennsylvania and a BA degree from Syracuse University. Mr. Watson’s business experience and educational background makes him qualified to serve as a director of CEL-SCI. He serves on the Audit, Compensation, and Nominating committees. |
| 2021-05-18 | Robert Watson 63 Director, Independent Audit, Compensation, and Nominating |
| 2022-04-29 | Robert Watson 65 Director, Independent Audit, Compensation, and Nominating committees |
| 2023-04-10 | Robert Watson 66 Director, Independent Audit, Compensation, and Nominating committees |
| 2024-03-07 | Mr. Watson has over 40 years of experience in the healthcare information technology industry as a CEO, board member and advisor to multiple healthcare information technology companies. |
Data sourced from SEC filings. Last updated: 2025-08-30